Literature DB >> 19661287

Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis.

Aadil El Firar1, Thierry Voisin, Christiane Rouyer-Fessard, Mariano A Ostuni, Alain Couvineau, Marc Laburthe.   

Abstract

The orexin neuropeptides promote robust apoptosis in cancer cells. We have recently shown that the 7-transmembrane-spanning orexin receptor OX1R mediates apoptosis through an original mechanism. OX1R is equipped with a tyrosine-based inhibitory motif ITIM, which is tyrosine-phosphorylated on receptor activation, allowing the recruitment and activation of the tyrosine phosphatase SHP-2, leading to apoptosis. We show here that another motif, immunoreceptor tyrosine-based switch motif (ITSM), is present in OX1R and is mandatory for OX1R-mediated apoptosis. This conclusion is based on the following observations: 1) a canonical ITSM sequence is present in the first intracellular loop of OX1R; 2) mutation of Y(83) to F within ITSM abolished OX1R-mediated apoptosis but did not alter orexin-induced inositol phosphate formation or calcium transient via coupling of OX1R to G(q) protein; 3) mutation of Y(83) to F further abolished orexin-induced tyrosine phosphorylation in ITSM and subsequent recruitment of SHP-2 by the receptor. Finally, we developed a structural model of OX1R showing that the spatial localization of phosphotyrosines in ITSM and ITIM in OX1R is compatible with their interaction with the two SH2 domains of SHP-2. These data represent the first evidence for a functional role of an ITSM in a 7-transmembrane-spanning receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661287     DOI: 10.1096/fj.09-131367

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  20 in total

1.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 2.  Targeting the programmed death-1 pathway in lymphoid neoplasms.

Authors:  Chi Young Ok; Ken H Young
Journal:  Cancer Treat Rev       Date:  2017-02-11       Impact factor: 12.111

Review 3.  The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs.

Authors:  Marc Laburthe; Thierry Voisin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 4.  Orexin/hypocretin receptor signalling cascades.

Authors:  J P Kukkonen; C S Leonard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

5.  Comparative analysis of nonaspanin protein sequences and expression studies in zebrafish.

Authors:  Benoist Pruvot; Véronique Laurens; Françoise Salvadori; Eric Solary; Laurent Pichon; Johanna Chluba
Journal:  Immunogenetics       Date:  2010-09-04       Impact factor: 2.846

6.  Orexin receptors in GtoPdb v.2021.3.

Authors:  Paul Coleman; Luis de Lecea; Anthony Gotter; Jim Hagan; Daniel Hoyer; Thomas Kilduff; Jyrki P Kukkonen; Rod Porter; John Renger; Jerome M Siegel; Gregor Sutcliffe; Neil Upton; Christopher J Winrow
Journal:  IUPHAR BPS Guide Pharm CITE       Date:  2021-09-02

7.  Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.

Authors:  Pascal Nicole; Pierre Couvineau; Nadege Jamin; Thierry Voisin; Alain Couvineau
Journal:  Br J Pharmacol       Date:  2015-09-30       Impact factor: 8.739

8.  Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor.

Authors:  David Duguay; Erika Bélanger-Nelson; Valérie Mongrain; Anna Beben; Armen Khatchadourian; Nicolas Cermakian
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

9.  Orexin-1 receptor co-localizes with pancreatic hormones in islet cells and modulates the outcome of streptozotocin-induced diabetes mellitus.

Authors:  Ernest Adeghate; Maria Fernandez-Cabezudo; Rashed Hameed; Hussain El-Hasasna; Mohamed El Wasila; Tariq Abbas; Basel Al-Ramadi
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

10.  Orexin A suppresses the growth of rat C6 glioma cells via a caspase-dependent mechanism.

Authors:  Kaja Biegańska; Paulina Sokołowska; Olaf Jöhren; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2012-05-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.